Fennec Pharmaceuticals Inc. (FENC) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 2.38M | -5.96M | 1.49M | -3.69M | -4.32M | -1.47M | -2.21M | -8.39M | 39.05M | -4.86M | -2.76M | -3.95M |
| Operating CF Margin % | 15.75% | -43.28% | 11.98% | -38.19% | -49.34% | -18.6% | -31.63% | -115.49% | 153.87% | -49.92% | -42.36% | -118.68% |
| Operating CF Growth % | 155.09% | -304.48% | 167.68% | 56.05% | -111.06% | 69.67% | 20.07% | -112.54% | 800.14% | 28.55% | 44.91% | -16.4% |
| Net Income | 201K | -4.79M | -637K | -3.15M | -1.17M | -1.99M | -5.74M | -5.55M | 12.84M | -2.68M | -1.87M | -5.44M |
| Depreciation & Amortization | 26K | 1K | 51K | 25K | 39K | 121K | 46K | 49K | 743K | 0 | 72K | 73K |
| Stock-Based Compensation | 0 | 2.52M | 2.22M | 1.49M | 798K | 1.12M | 1.82M | 925K | 1.19M | 857K | 865K | 2.54M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 937K | 5.56M | -7.42M | 1.16M | 80K | -1.41M | 3.41M | -352K | 27.08M | 66K | 626K | 58K |
| Working Capital Changes | 1.21M | -9.25M | 7.28M | -3.21M | -4.07M | 678K | -1.75M | -3.46M | -2.81M | -3.1M | -2.46M | -1.18M |
| Change in Receivables | 4.51M | -3.51M | -3.44M | -265K | -5.28M | -175K | -4.2M | -2.04M | -1.46M | -4.29M | -2.08M | -762K |
| Change in Inventory | -291K | 142.45K | 624K | -797K | -344K | 65K | 502K | -80K | 92K | -401K | -316K | -521K |
| Change in Payables | 1.65M | -1.25M | -75K | 661K | 2.04M | 0 | 0 | 0 | 0 | 837K | 0 | 0 |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 1.01M | 20.8M | 1.75M | -284K | 359K | -12.21M | -528K | 257K | -1.13M | 5.73M | 201K | 514K |
| Debt Issued (Net) | 0 | -19.82M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5M | 0 | 0 |
| Equity Issued (Net) | 1.32M | 42.99M | -171.41K | -198.47K | 369.88K | -9K | -528K | -90K | -19K | 0 | -14K | -27K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -9K | -528K | -90K | -19K | 0 | -14K | -27K |
| Other Financing | -311K | -2.37M | 1.92M | -85.53K | -10.88K | -12.2M | 0 | 347K | -1.11M | 733K | 215K | 541K |
| Net Change in Cash | 3.39M | 14.84M | 3.24M | -3.97M | -3.96M | -13.69M | -2.73M | -8.13M | 37.91M | 870K | -2.56M | -3.43M |
| Free Cash Flow | 2.38M | -5.96M | 1.49M | -3.69M | -4.32M | -1.47M | -2.21M | -8.39M | 39.05M | -4.86M | -2.76M | -3.95M |
| FCF Margin % | 15.75% | -43.28% | 11.98% | -38.19% | -49.34% | -18.6% | -31.63% | -115.49% | 153.87% | -49.92% | -42.36% | -118.68% |
| FCF Growth % | 155.09% | -304.48% | 167.68% | 56.05% | -111.06% | 69.67% | 20.07% | -112.54% | 800.14% | 28.55% | 44.91% | -16.4% |
| FCF per Share | 0.07 | -0.19 | 0.05 | -0.13 | -0.16 | -0.05 | -0.08 | -0.31 | 1.26 | -0.18 | -0.10 | -0.15 |
| FCF Conversion (FCF/Net Income) | 11.84x | 1.25x | -2.34x | 1.17x | 3.71x | 0.74x | 0.38x | 1.51x | 3.04x | 1.81x | 1.48x | 0.72x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |